ΕπόμενοΕπόμενος οδηγός
EU MDR and AI Medical Devices
Κοινωνία
ΟΔΗΓΟΣ Κοινωνίας
Software as a Medical Device (SaMD) is software intended for a medical purpose that can perform that purpose without being part of a hardware medical device.
Intended use, users, and patient risk shape regulatory assessment. A product label or use of AI alone does not determine whether software is a medical device; manufacturers evaluate the specific function and applicable jurisdiction.
Software as a Medical Device refers to software intended to be used for one or more medical purposes that performs those purposes without being part of a hardware medical device. Examples may include software that analyzes medical images or supports a defined clinical decision. Software embedded in a device, software that controls hardware, and general wellness apps may follow different regulatory paths. Classification depends on intended use, claims, functionality, and the law of the market where the software is offered. FDA’s guidance on device software functions distinguishes software functions that are medical devices from those that may not be. A model’s use of machine learning does not itself establish regulatory status. The manufacturer defines intended use and users, evaluates risks, and determines whether premarket authorization or other controls apply. Changes to algorithms, data inputs, or user workflows can affect performance and may require regulatory assessment and change control. Healthcare organizations should verify the product’s labeling, authorization status, supported users and populations, compatible inputs, and limitations. Do not assume that a product authorized for one task or population is suitable for another. SaMD requires quality processes, cybersecurity, post-market monitoring, and clear instructions. This overview explains the concept but does not classify a particular product or replace regulatory advice. A supplier should document the product boundary, including any cloud services, hardware dependencies, and third-party algorithms. Users should also understand whether the output is informational or intended to influence clinical action.
Οι καταστροφικές και οι καθημερινές βλάβες της τεχνητής νοημοσύνης εξαρτώνται από το ποιος κατανοεί τους κινδύνους και ποιος μπορεί να δράσει.
Ο δημόσιος και επαγγελματικός γραμματισμός διαμορφώνει εάν είναι πολιτικά δυνατή η ισχυρή πολιτική ασφάλειας.
Οι σαφείς εξηγήσεις μειώνουν τη λήψη από διαφημιστική εκστρατεία, εργαστηριακές σχέσεις δημοσίων σχέσεων και αόριστες θεατρικές ηθικές.
Software-based medical functions will continue to evolve as models update and connect to new data sources. Regulators and standards bodies are developing approaches for lifecycle oversight and software changes. Manufacturers should maintain evidence and change controls throughout product use. Providers should confirm that deployed software matches its authorized use and continue monitoring safety and performance after implementation. Ongoing evaluation can reveal changes in performance after deployment. Maintain a process to suspend or roll back a release when evidence shows unexpected risk.
A developer documents whether software analyzes images to support diagnosis or only stores files.
A manufacturer evaluates whether a model update changes the software’s intended medical purpose.
A health system checks authorization and labeling before using a SaMD product.
A software team separates wellness features from functions that make medical claims.
Αντιμετώπιση του υπαρξιακού κινδύνου ως ενώσεις επιστημονικής φαντασίας και ικανότητας.
Συγχέοντας την ασφάλεια του προϊόντος της επιφάνειας με την ευθυγράμμιση υπό υψηλή αυτονομία.
Αφήνοντας μη αγγλικά και μη εξειδικευμένα είδη κοινού με πηγές μόνο χαμηλής ποιότητας.
Ξεχωρίστε τους κινδύνους βλαβών, κακής χρήσης και απώλειας ελέγχου / κακής ευθυγράμμισης του προϊόντος.
Ρωτήστε ποια στοιχεία θα άλλαζαν την άποψή σας για τα χρονοδιαγράμματα και τη σοβαρότητα.
Προτιμήστε τις πρωτογενείς πηγές και τις συγκεκριμένες αξιολογήσεις έναντι των ισχυρισμών μάρκετινγκ.
Προσδιορίστε ένα μονοπάτι δράσης: καριέρα, πολιτική, χρηματοδότηση ή δεξιότητες — όχι μόνο ευαισθητοποίηση.
Free newsletter
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
Software as a Medical Device (SaMD) is software intended for a medical purpose that can perform that purpose without being part of a hardware medical device. Intended use, users, and patient risk shape regulatory assessment. A product label or use of AI alone does not determine whether software is a medical device; manufacturers evaluate the specific function and applicable jurisdiction.
SaMD describes an independently functioning software medical purpose.
A function without medical purpose may be assessed differently.
Lifecycle documentation ties evidence to the shipped product.
Classification depends on intended use and applicable rules.
Συνέχισε να μαθαίνεις
Επιλέχθηκαν περισσότεροι οδηγοί για αυτό το θέμα
ΕπόμενοΕπόμενος οδηγός
EU MDR and AI Medical Devices
Κοινωνία